WO2000065347A2 - Dispositif pour diagnostics multiples de la sante de la femme - Google Patents

Dispositif pour diagnostics multiples de la sante de la femme Download PDF

Info

Publication number
WO2000065347A2
WO2000065347A2 PCT/US2000/011207 US0011207W WO0065347A2 WO 2000065347 A2 WO2000065347 A2 WO 2000065347A2 US 0011207 W US0011207 W US 0011207W WO 0065347 A2 WO0065347 A2 WO 0065347A2
Authority
WO
WIPO (PCT)
Prior art keywords
biosensor
detect
absorbent article
diagnostic device
health
Prior art date
Application number
PCT/US2000/011207
Other languages
English (en)
Other versions
WO2000065347A9 (fr
WO2000065347A3 (fr
Inventor
John Lee Hammons
Donald Carroll Roe
Original Assignee
The Procter & Gamble Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/299,399 external-priority patent/US6713660B1/en
Application filed by The Procter & Gamble Company filed Critical The Procter & Gamble Company
Priority to CA002370739A priority Critical patent/CA2370739A1/fr
Priority to JP2000614036A priority patent/JP2003517584A/ja
Priority to EP00930160A priority patent/EP1173758A2/fr
Priority to MXPA01010946A priority patent/MXPA01010946A/es
Priority to AU48029/00A priority patent/AU4802900A/en
Publication of WO2000065347A2 publication Critical patent/WO2000065347A2/fr
Publication of WO2000065347A3 publication Critical patent/WO2000065347A3/fr
Publication of WO2000065347A9 publication Critical patent/WO2000065347A9/fr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G01N33/721—Haemoglobin
    • G01N33/725—Haemoglobin using peroxidative activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/15—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
    • A61F13/42—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators with wetness indicator or alarm
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/15—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
    • A61F13/45—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterised by the shape
    • A61F13/47—Sanitary towels, incontinence pads or napkins
    • A61F13/472—Sanitary towels, incontinence pads or napkins specially adapted for female use
    • A61F13/47263—Sanitary towels, incontinence pads or napkins specially adapted for female use with activating means, e.g. elastic, heat or chemical activatable means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/15—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
    • A61F13/56—Supporting or fastening means
    • A61F13/66—Garments, holders or supports not integral with absorbent pads
    • A61F13/82—Garments, holders or supports not integral with absorbent pads with means for attaching to the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/15—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
    • A61F13/84—Accessories, not otherwise provided for, for absorbent pads
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/56—Wetness-indicators or colourants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • G01N33/528—Atypical element structures, e.g. gloves, rods, tampons, toilet paper
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/15—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
    • A61F13/84—Accessories, not otherwise provided for, for absorbent pads
    • A61F2013/8473—Accessories, not otherwise provided for, for absorbent pads for diagnostic purposes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/15—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
    • A61F13/84—Accessories, not otherwise provided for, for absorbent pads
    • A61F2013/8476—Accessories, not otherwise provided for, for absorbent pads with various devices or method
    • A61F2013/8479—Accessories, not otherwise provided for, for absorbent pads with various devices or method including electric or magnetic devices
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/84—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving inorganic compounds or pH

Definitions

  • the present invention relates to a multiple diagnostic device which detects two or more types of hormones related to a woman's menstrual cycle, ovulation, pre-menstrual syndrome and pregnancy. Also, the multiple diagnostic device may be placed within or in a conventional type of feminine protection absorbent article and an incontinent absorbent article. The multiple diagnostic device may also be used to detect one or more types of bacteria, virus and other known disease indicators.
  • disposable articles such as absorbent articles, adult incontinence briefs, sanitary napkins and tampons, are widely used in infant and toddler care and in the care of incontinent or menstruating adults as a means of containing, isolating and disposing of bodily wastes. These articles have generally replaced reusable, washable cloth garments as the preferred means for these applications because of their convenience and reliability.
  • the disposable articles respond to a defecation, urination or discharge event by absorbing or containing bodily wastes deposited on the article. Some disposable articles also signal a defecation, urination or discharge event after it has occurred (e.g., wetness indicators, temperature change detection).
  • the invention provides a multiple diagnostic device for a woman's health comprising a biosensor being able to detect multiple target analytes in a woman's bodily fluids and on or through the skin, wherein the analytes are germane to a women's health.
  • the bodily fluids consist of vaginal secretions, menses, blood, urine and saliva.
  • the biosensor comprises at least one bio-recognition element for use in detecting multiple biological analytes.
  • biological analytes tested are germane to a woman's health indicating at least one of the following including 1) the onset of menstruation, 2) the presence of ovulation, 3) the presence of a sexually transmitted disease, 4) the state of pregnancy, 5) the presence of infection, 6) the presence of hormone fluctuations, 7) ovarian reserve, 8) the presence of menopause, 9) the presence of osteoporosis, 10) the presence of an iron deficiency, 11) electrolyte balance, 12) nutritional status, 13) stress level and 14) combinations thereof.
  • an absorbent article may comprise the multiple diagnostic device of the present invention.
  • the absorbent article is a conventional one known in the art having a topsheet, a backsheet joined to the topsheet, and an absorbent core positioned between the topsheet and the backsheet.
  • the topsheet has a top surface facing a user and a bottom surface facing away from a user.
  • the multiple diagnostic device may be positioned on the top surface of the topsheet.
  • the multiple diagnostic device may be positioned between the topsheet and the backsheet of the absorbent article.
  • the multiple diagnostic device will be positioned adjacent to the bottom surface of the topsheet and above the absorbent core.
  • the multiple diagnostic device may also be placed within the absorbent core of the absorbent article.
  • Ideal absorbent articles for the invention herein include one selected from the group consisting of a sanitary napkin, an interlabial device, a tampon, a patch, a liquid collection device, an incontinent device and combinations thereof.
  • sanitary napkin or “napkin” refers to an absorbent article which is worn by females adjacent to the pudendal region, generally external to the urogenital region, and which is intended to absorb and contain menstrual fluids and other vaginal discharges from the wearer's body (e.g., blood, menses, and urine).
  • the term “pudendal” refers to the externally visible female genitalia. It should be understood, however, that the present invention is also applicable to other feminine hygiene or catamenial pads such as pantiliners, or other absorbent articles such as incontinence pads, and the like.
  • zone of menses insult it is meant herein that area on the sanitary napkin most likely to consistently receive a menses discharge from a female wearer.
  • panty liners and sanitary napkins which may be provided with a diagnostic device include those manufactured by The Procter & Gamble Company of Cincinnati, Ohio as: ALWAYS® Pantiliners with DriWeave® manufactured according to U.S. Patent Nos. 4,324,246; 4,463,045; and 6,004,893; ALWAYS® Ultrathin Slender Maxi with Wings manufactured according to U.S. Patent Nos. 4,342,314, 4,463,045, 4,556,146, Bl 4,589,876, 4,687,478, 4,950,264, 5,009,653, 5,267,992, and Re.
  • FIG. 1 and 1A An example of a panty liner with a diagnostic device is shown in Figs. 1 and 1A.
  • An example of a sanitary napkin with a diagnostic device is shown in Fig. 2.
  • Non-limiting examples of tampons which may be provided with a diagnostic device, and applicators therefor, are described in U.S. Patent Nos. 4,726,805; 4,846,802; 4,960,417; 5,087,239; 5,279,541; 5,346,468; 5,348,534; 5,531,674; and 5,566,435.
  • the diagnostic device could also be placed on a digitally insertable tampon.
  • An example of a tampon with a diagnostic device is shown in Fig. 5.
  • the cyclic nature of the hormones of the menstrual cycle make them useful in understanding fertility and, in general, the position of an individual during her cycle. This goes beyond current uses of hormones to predict ovulation and pregnancy. For example, progesterone peaks and then drops just prior to menstruation. Estrogen also declines just prior to menstruation. Thus, in combination, assay for these two hormones will allow reliable prediction of the onset and the presence of menstruation. The timing of the peak of these hormones, along with their subsequent drop, may allow an almost daily marking of the time before menstruation.
  • Follicle Stimulating Hormone exhibits a peak about one week prior to ovulation, giving more advance timing for pregnancy planning than assays for the luteinizing hormone, which exhibits a sharp peak at the time of ovulation. Two to three days of fertility may be missed when relying only on assay of the luteinizing hormone.
  • FSH Follicle Stimulating Hormone
  • a rise in Follicle Stimulating Hormone to a near constant amount signals the approach of menopause. This may be of use in planning healthy approaches to menopause, such as Hormone Replacement Therapy, nutritional changes, and checks for osteoporosis.
  • a diagnostic testing for multiple hormones presents a much broader and more useful information set to a woman than single tests of individual cycle information proposed by the prior art.
  • Technologies which allow multiple analyte assays are thus of potential use in this invention proposed by the prior art. These include, but are not limited to, antibody labeled microbeads, Silas TM surface analysis, or membrane based biosensors.
  • SILASTM or SILICON Assay Surface Technology is a proven method for the detection of specific target molecules. This thin film based technology has successfully been used for the development of diagnostic tests to detect bacterial and viral antigens from Group A Streptococcus, Group B Streptococcus, Chlamydia, and Influenza A and B (Optical Immunoassay (OIA®)).
  • the wafer consists of a silicon support with an optical coating and attachment layer.
  • This wafer surface technology enables the direct visual detection of a physical change in the optical thickness of molecular thin films. This change in thickness is due to the specific capture of an analyte on the surface. When a substrate is added, this binding event is amplified and again increases the surface thickness of the molecular thin film. This change in thickness alters the reflected light path and is visually perceived as a color change. Slight changes in optical thickness produce a distinct visible color change. A positive result appears as a purple spot on the predominant gold background. When a target is not present in the sample, no binding takes place. Therefore, the optical thickness remains unchanged and the surface retains the original gold color indicating a negative result.
  • the invention features a device for detecting the amount or presence of an analyte of interest.
  • the device includes a substrate which has an optically active surface exhibiting a first color in response to light impinging thereon. This first color is defined as a spectral distribution of the emanating light.
  • the substrate also exhibits a second color which is different from the first color (by having combination of wavelengths of light which differ from that combination present in the first color, or having a different spectral distribution, or by having an intensity of one or more of those wavelengths different from those present in the first color).
  • the second color is exhibited in response to the same light when the analyte is present on the surface.
  • optically active surface is a surface that participates in the generation of an optical effect such that the light impinging upon that surface is in some way altered.
  • Such optically active surfaces may be adapted to respond not only to polychromatic light (e.g., white light) but also to mono-chromatic light (e.g., laser light, which may be inherently polarized).
  • Devices of this invention preferably produce a color signal that strongly contrasts the background interference color of the unreacted test surface and a reacted surface.
  • the invention features similar devices in which the substrate has an attachment layer formed from a chemical selected from the group consisting of dendrimers, star polymers, molecular self-assembling polymers, polymeric siloxanes, and film forming latexes; the substrate itself is formed from a material selected from the group consisting of monocrystalline silicon, a amorphous silicon on glass, amorphous silicon on plastic, a ceramic, polycrystalline silicon, and composites of these materials; and the substrate may have an optical thin film formed from a material selected from the group consisting of silicon nitride, silicon/silicon dioxide composites, titanates, diamond, oxides of zirconium, and silicon carbide.
  • the substrate is selected from the group consisting of glass, and plastic, comprising a layer of amorphous silicon on its surface, whereby an optically active surface is produced; the optically active surface includes monocrystalline silicon or metal; the substrate in metal further having a layer of amorphous silicon; a receptor layer receptive to an analyte is provided with a specific binding partner for the analyte; the receptor layer is formed from material selected from the group consisting of antigens, antibodies, oligonucleotides, chelators, enzymes, bacteria, bacterial pili, bacterial flagellar materials, nucleic acids, polysaccharides, lipids, proteins, carbohydrates, metals, viruses, hormones, and receptors for said materials; and the first color is golden in appearance and the second color is purple or blue in appearance to the eye.
  • the invention features a method for detecting an analyte of interest in a sample, by the steps of providing a thin film optical immunoassay device having a substrate, having an upper and a lower surface, and supporting on its upper surface, an unlabeled antibody layer bound to the substrate, at least one layer containing the analyte from the sample, the analyte containing layer supporting at least one layer having an enzyme conjugate complex with the analyte; contacting the enzyme conjugate with a precipitating agent; incubating for a time period sufficient to cause precipitation of product from interaction of the precipitating agent and the enzyme; and optically measuring the mass change of the enzyme conjugate layer and the unlabeled antibody layer as an indication of the amount of the analyte in the test sample.
  • the enzyme conjugate has an immobilized peroxidase or an antibacterial anti-body-horseradish peroxidase complex; or the enzyme conjugate is alkaline phosphatase and comprises an anti-bacterial -antibody- alkaline phosphatase complex; and the precipitating agent is a substrate containing 5-bromo-4chloro-3indolyl phosphate.
  • an array of sensors may be placed on a surface to be brought into contact with a suitable sample.
  • Samples include, but are not limited to urine, saliva, sweat, and vaginal discharge.
  • the sensor may be placed on the skin.
  • the individual sensors respond to their respective analytes and produce a visually detectable signal. This may be as simple as a color or refractive index change, or may involve a change in an electrical signal such as due to current flow through a biosensor membrane.
  • the latter type of assay lends itself to a device which may incorporate an algorithm to detect the changes in hormone levels. This may then be displayed in an easy to understand format for the user.
  • antibodies to the appropriate hormones may be immobilized on the surface of the Silas optical wafers by methods known in the art. These wafers may then be separated and arranged in a known pattern on a detection article, for example, an absorbent article. Similarly, these antibodies could be immobilized on microbeads and arranged in a lateral flow assay device suitable for urine or saliva matrices. Again, multiple reagents are used in an array giving readout of all analytes simultaneously. Also, other analytes may be detected in combination with hormones. These include biomarkers for other conditions of interest, such as infections, osteoporosis, etc.
  • Another immunoassay method comprises applying an aqueous solution containing the analyte antigen to one end of a multi-zoned test strip device such that the solution moves along the strip by capillary action.
  • the zones are arranged so that the solution (a) first contacts and reconstitutes dry, diffusible labeled component comprising colloidal gold conjugated to an antibody specific for said analyte antigen and then (b) contacts and reconstitutes dry, diffusible biotinylated second antibody specific for the analyte antigen such that a diffusible, dispersed sandwich reaction product forms.
  • the reaction product diffuses along the strip with the solution and into a zone containing capture component consisting of a latex and avidin complex.
  • the avidin collects the reaction product by means of reaction with its biotin moiety. Thus, gold particles are collected and concentrated in the detection zone for visual detection.
  • one or more of the sensors can be replaced by a sensor to detect pregnancy.
  • a new over-the-counter pregnancy test (Clearblue EasyTM), developed and patented by Unipath, was introduced.
  • the test uses dyed microspheres in a sandwich format to give a one step test.
  • small dark-blue dyed microspheres (O) are first coated with antibody (Abi) to HCG (human chorionic gonadotropin); the microspheres (O-Abi) are dried on one part of a nitrocellulose strip; a second antibody (Ab ) to HCG is immobilized on another section of the strip.
  • Absi human chorionic gonadotropin
  • the strip In use the strip is wetted at one end with urine. As the urine moves by capillary action, it picks up the blue microspheres (O-Abi), and carries them downstream; any HCG in the urine reacts with Ab* on the microspheres (O-Abi- HCG). When the flow reaches the immobilized Ab 2 -1, the dyed microspheres with HCG (O-Abi- HCG) are captured by Ab -I to form a blue line caused by the HCG sandwich (O-Abi- HCG- Ab 2 - 1). The blue line signals a positive pregnancy test.
  • the absorbent article herein i.e., sanitary napkins, interlabial devices, and tampons
  • a biosensor 60 includes a component comprising one or more elements being adapted to detect one or more hormones, target pathogenic microorganisms or related biomolecules (e.g., an enzyme sensor, organella sensor, tissue sensor, microorganism sensor, immunosensor or electrochemical sensor), additionally having the capability to provide a signal of said detection to the wearer, caretaker, or an actuator.
  • the elements may be biologically reactive, chemically reactive, binding, or they may operate by physical entrapment.
  • biologically reactive is defined as having the capability to selectively interact with, and preferably bind, target pathogenic microorganisms and/or related biomolecules as described herein.
  • biologically reactive includes, but is not limited to elements that detect the presence of enzymes.
  • biosensors function by providing a means of specifically binding, and therefore detecting, a target biologically active analyte. In this way, the biosensor is highly selective, even when presented with a mixture of many chemical and biological entities, such as feces, menses, sweat, and saliva.
  • Chemical sensors on the other hand, which rely on chemically reactive means, generally do not have either the high selectivity or the amplification properties of biosensors and, therefore, are not as well suited to detect biologically reactive analytes, especially when they are present in low concentrations and/or in a complex media such as bodily fluids, bodily waste, and other bodily discharges.
  • the target biological analyte is a minor component of a complex mixture comprising a multiplicity of biological and other components.
  • discrimination ratios of about 10 7 -10 8 or greater may be required for the biosensor to recognize the target biological analyte in a complex mixture.
  • the biosensor of the present invention comprises a bio-recognition element, or molecular recognition element, that provides the highly specific binding or detection selectivity for a particular analyte.
  • the bio-recognition element, or system may be a biologically derived material such as an enzyme or sequence of enzymes; an antibody; a membrane receptor protein; DNA; an organelle, a natural or synthetic cell membrane; an intact or partial viable or nonviable bacterial, plant or animal cell; or a piece of plant or mammalian tissues, and generally functions to interact specifically with a target biological analyte.
  • the bio-recognition element is responsible for the selective recognition of the analyte and the physico-chemical signal that provides the basis for the output signal.
  • Biosensors may include biocatalytic biosensors, and bioaffinity biosensors.
  • the bio-recognition element is "biocatalytic” and may comprise an enzyme, organelle, piece of plant or mammalian tissue, or whole cells, the selective binding sites "turn over" (i.e., can be used again during the detection process), resulting in a significant amplification of the input signal.
  • Biocatalytic sensors such as these are generally useful for real-time, continuous sensing.
  • Bioaffinity sensors are generally applicable to bacteria, viruses, and toxins and include chemoreceptor-based biosensors and/or immunological sensors (i.e. immunosensors).
  • Chemoreceptors are complex biomolecular macroassemblies responsible, in part, for a viable organism's ability to sense chemicals in its environment with high selectivity.
  • Chemoreceptor-based biosensors comprise one or more natural or synthetic chemoreceptors associated with a means to provide a signal (visual, electrical, etc.) of the presence or concentration of a target biological analyte.
  • the chemoreceptor may be associated with an electrode (i.e., an electrical transducer) so as to provide a detectable electrical signal.
  • Chemoreceptors may include whole or partial nerve bundles (e.g., from antennae or other sensing organs) and/or whole or partial natural or synthetic cell membranes.
  • the bio-recognition elements of immunosensors are generally antibodies. Antibodies are highly specific and can be made toward bacteria, viruses, fragments of microorganisms (e.g., bacterial cell walls, parasite eggs or portions thereof, etc.), and large biomolecules. Suitable antibodies may be monoclonal or polyclonal. In any case, bioaffinity biosensors are generally irreversible because the receptor sites of the biosensor become saturated when exposed to the target biological analyte.
  • biocatalytic bioaffinity biosensors may be combined, such as RNA/DNA probes or other high-affinity binding systems wherein the initial bio- recognition event is followed by biological amplification of the signal.
  • a specific bacteria may be detected by a biosensor comprising genetic material, such as DNA, as a bio-recognition element and PCR (i.e., polymerase chain reaction) amplification to detect small numbers of organisms, preferably less than or equal to about 500.
  • Biocatalytic and bioaffinity biosensor systems are described in more detail in Journal of Chromatography, 510 (1990) 347-354 and in the Kirk-Othmer Encvclopedia of Chemical Technology, 4 th ed. (1992), John Wiley & Sons, NY, the disclosure of which is incorporated by reference herein.
  • the biosensors of the present invention preferably detect biologically active analytes related to impending (i.e., future presentation of symptoms is likely) or current human systemic disease states, including, but not limited to, pathogenic bacteria, parasites (e.g., any stage of the life cycle, including eggs or portions thereof, cysts, or mature organisms), viruses, fungi such as Candida alhicans, antibodies to pathogens, and/or microbially produced toxins. Additionally, the biosensor may target biologically active analytes related to impending or current localized health issues, such as stress proteins (e.g., cytokines) and IL-l ⁇ (interleukin 1 -alpha) that may precede the clinical presentation of skin irritation or inflammation.
  • stress proteins e.g., cytokines
  • IL-l ⁇ interleukin 1 -alpha
  • the biosensor functions as a proactive sensor, detecting and signaling the wearer or caretaker of the impending condition prior to the presentation of clinical symptoms. This allows time to administer prophylactic or remedial treatments to the wearer which can significantly reduce, if not prevent, the severity and duration of the symptoms. Further, the biosensor, by detecting the presence of a target biological analyte in the wearer's bodily waste (e.g., menses), may detect residual contamination on a surface, such as skin, in contact with the biosensor, and provide an appropriate signal.
  • a target biological analyte in the wearer's bodily waste e.g., menses
  • the physico-chemical signal generated by the bio-recognition element or elements may be communicated visually to the wearer or caretaker (i.e., via a color change visible to the human eye as in a colorimetric sensor).
  • Other embodiments may produce optical signals, which may require other instrumentation to enhance the signal. These include flourescence, bioluminesence, total internal reflectance resonance, surface plasmon resonance, Raman methods and other laser-based methods.
  • Exemplary surface plasmon resonance biosensors which may comprise bioconjugate surfaces as bio-recognition elements are available as LBIS I and IBIS II from XanTec Analysensysteme of Muenster, Germany.
  • the signal may be processed via an associated transducer which, for example, may produce an electrical signal (e.g., current, potential, inductance, or impedance) that may be displayed (e.g., on a readout such as an LED or LCD display) or which triggers an audible or tactile (e.g., vibration) signal or which may trigger an actuator, as described herein.
  • the signal may be qualitative (e.g., indicating the presence of the target biological analyte) or quantitative (i.e., a measurement of the amount or concentration of the target biological analyte).
  • the transducer may optionally produce an optical, thermal or acoustic signal.
  • the signal may also be durable (i.e., stable and readable over a length of time typically at least of the same magnitude as the usage life of the article) or transient (i.e., registering a real-time measurement). Additionally, the signal may be transmitted to a remote indicator site (e.g., via a wire, or transmitter, such as an infrared or rf transmitter) including other locations within or on the article or remote devices.
  • a remote indicator site e.g., via a wire, or transmitter, such as an infrared or rf transmitter
  • the biosensor may be adapted to detect and/or signal only concentrations of the target biological analyte above a predefined threshold level (e.g., in cases wherein the target biological analyte is normally present in the bodily fluids, bodily waste, or other bodily discharges, or when the concentration of the analyte is below a known "danger" level).
  • a predefined threshold level e.g., in cases wherein the target biological analyte is normally present in the bodily fluids, bodily waste, or other bodily discharges, or when the concentration of the analyte is below a known "danger" level.
  • the target analytes that the biosensors of the present invention are adapted to detect may be pathogenic microorganisms such as the pathogenic microorganisms implicated in human gastrointestinal diseases, especially those resulting in diarrhea. This type of pathogen is particularly important to monitor due to the number of children who become seriously ill or die each year from diarrheal diseases.
  • pathogenic bacteria that the biosensor may detect include any of the various pathogenic strains of Escherichia coli (commonly known as E. Coli), including enteropathenogenic E. coli ( ⁇ P ⁇ C), enterotoxigenic E. coli ( ⁇ T ⁇ C), enterohemorragic E. coli ( ⁇ H ⁇ C), enteroinvasive E. coli ( ⁇ L ⁇ C), and enteroadherent E. coli ( ⁇ A ⁇ C) strains; Salmonella strains, including S. typhi, S. paratyphi, S. enteriditis, S. typhimurium, and S.
  • E. Coli any of the various pathogenic strains of Escherichia coli (commonly known as E. Coli), including enteropathenogenic E. coli ( ⁇ P ⁇ C), enterotoxigenic E. coli ( ⁇ T ⁇ C), enterohemorragic E. coli ( ⁇ H ⁇ C), enteroinvasive E. coli ( ⁇ L ⁇ C), and enteroadherent
  • Shigella strains such as Shigella sonnei, Shigella flexneri, Shigella boydii, and Shigella dysenteriae; Vibrio cholerae; Mycobacterium tuberculosis,' Yersinia enterocolitica; Aeromonas hydrophila; Plesiomonas shigelloides; Campylobacter strains such as C. jejuni and C. coli; Bacteroides fragilis; and Clostridia strains, including C. septicum, C. perfringens, C. botulinum, and C. difficile.
  • Non-limiting examples of commercially available biosensors adapted to detect E. coli are available from AndCare, Inc.
  • the target analytes that the biosensors of the present invention are adapted to detect may also be viruses. These may include diarrhea-inducing viruses such as rotavirus, adenovirus (a dsDNA virus), astrovirus (an RNA virus), calcivirus (an RNA virus), and Norwalk viruses (RNA viruses), or other viruses such as rhinovirus and human immunodeficiency virus (HIN).
  • a virus adenovirus
  • astrovirus an RNA virus
  • calcivirus an RNA virus
  • RNA viruses Norwalk viruses
  • An exemplary biosensor adapted to detect HIN is described in U.S. Patent ⁇ os. 5,830,341 and 5,795,453, referenced above. The disclosure of each of these patents is incorporated by reference herein.
  • the target analytes that the biosensors of the present invention are adapted to detect may also be parasites, especially those which inhabit the gastrointestinal tract during some point in their life-cycle (e.g., eggs or portions thereof, oocytes, trophozoites, adults).
  • parasites may include protozoans, worms, and other gastrointestinal parasites.
  • Other examples of parasites which may be detected include Entamoeba histolytica (which cause amoebic dysentery), cryptosporidium, Giardia lamblia, and Dientomeba fragilis, Trypana cruzi (which causes Chagas disease), and Plasmodium falciparum .
  • the target analytes the biosensors of the present invention are adapted to detect may be fungi such as Candida albicans.
  • certain beneficial colonic bacteria may be detected and/or measured as a health indicator, such as Bifidobacteria and Lactobacillus strains.
  • the target analytes that the biosensors of the present invention are adapted to detect may also be proteins or antigens related to skin distress.
  • these analytes are detectable on or at the skin surface, preferably prior to the presentation of clinically observable skin irritation.
  • These may include stress proteins such as cytokines, histamine, and other immune response factors including interleukins (such as IL-l , LL-2, IL-3, IL-4, and IL-8) and interferons (including interferons a and g).
  • these are preferably detectable by the biosensor 60 prior to the onset of clinically observable redness, irritation, or dermatitis.
  • the biosensors of the present invention may be adapted to detect enzymes, or other biological factors, implicated in skin irritation (e.g., absorbent article dermatitis), including tryspin, chymotrypsin, and lipase.
  • the article may comprise a diagnostic panel.
  • a "diagnostic panel”, as used herein, comprises the combination of two or more biosensors, or other types of indicators, adapted to detect the presence of at least two of a specific group of substances. These substances can be indicators of the physical conditions or state of well being of a user, or the cause of a particular disease state, such as diarrhea, vaginal infections, sexually transmitted diseases (“STD's”), and other diseases.
  • the biosensors can, for example, be adapted to detect the presence of at least two of a specific group of pathogens for the purpose of determining the class of pathogens or specific pathogen(s) causing a particular disease state, generally in order to provide a diagnosis leading to a specific course of remedial medical treatment.
  • the article may comprise a diagnostic panel adapted to determine the pathogenic cause, or causes, of diarrhea or vaginal infections.
  • Examples of physical conditions or the state of well being that the diagnostic panel can be adapted to detect include, but are not limited to ovulation and the onset of menstruation.
  • substances that the diagnostic panel can be adapted to detect in order to determine the onset of menstruation include, but are not limited to: progesterone, pH, and red blood cells (hemoglobin).
  • the article may comprise a diagnostic panel adapted to detect any of the potential bacterial causes of diarrhea or vaginal infections.
  • the diagnostic panel may comprise biosensors adapted to detect at least two of the following group of bacteria: EPEC, ETEC, EHEC, EAEC, ELEC, Campylobacter jejuni, Vibrio cholerae, and Shigella strains, including S. sonnei and S. flexneri.
  • the presence of any of the above bacterial causes of diarrhea or vaginal infections are indicated by the diagnostic panel.
  • the signal to the user, caretaker, or health professional from the diagnostic panel preferably indicates the specific cause (i.e., bacterial pathogen) of the diarrhea or vaginal infections, allowing the early and specific treatment of the health condition.
  • the article may comprise a diagnostic panel adapted to detect any of the potential viral and bacterial causes of vaginal infections.
  • the diagnostic panel may comprise one or more biosensors adapted to detect at least one virus and one or more biosensors adapted to detect at least one bacteria.
  • the signal to the user, caretaker, or health professional from the diagnostic panel preferably indicates the specific cause of vaginal infections, allowing the early and specific treatment of the health condition.
  • FIG. 6B-6E A non-limiting embodiment of an exemplary diagnostic panel 10 suitable for incorporation into a disposable absorbent article is shown in Figures 6B-6E.
  • the diagnostic panel 10 includes two biosensors 12, a biosensor 14 adapted to detect E. coli H0157 and a biosensor 16 adapted to detect rotavirus.
  • the diagnostic panel 10 may be made by obtaining biosensors 12 from the hereinbefore mentioned 7ww ⁇ moCard®STAT! E. coli 0157 Plus and 7 mw «oCard®STAT! Rotavirus kits, available from Meridian Diagnostics.
  • the biosensors are removed from their respective "cards" and attached to an exposed surface of a substrate 18 via any attachment or bonding means as known in the art, such as an adhesive.
  • the substrate 18 is preferably a stiff cardboard material, although it may comprise any substrate such as paper, cardboard, a polyolefinic film, etc.
  • a mask 20 having openings corresponding to the biosensors 12 may be applied to the surface of the substrate 18 to ensure fluid/waste contact only with the biosensors 12 themselves and not the remainder of the substrate 18 surface.
  • the substrate 18, or mask 20, may be made of any material such as plastic, cardboard, or paper, and may comprise markings, instructions, or other indicia to aid in performance of the test or the interpretation of the results.
  • the substrate 18 may comprise a color change "key" to assist the user in the correct interpretation of the results.
  • the diagnostic panel 10 is attached to the wearing- facing surface of the absorbent article topsheet in the crotch region of the absorbent article corresponding to the location of a female wearer's pudendal region via any attachment or bonding means as known in the art, such as an adhesive.
  • the diagnostic panel may be made by attaching the hereinbefore mentioned E. coli 0157 Plus and 7mmw «oCard®STAT! Rotavirus biosensors directly to the wearing-facing surface of the absorbent article topsheet in the region of the absorbent article corresponding to the location of a female wearer's pudendal region.
  • the absorbent article topsheet may comprise at least one aperture and the diagnostic panel 15 may be attached to the region of the underlying absorbent core corresponding to the topsheet aperture(s).
  • the fluid/waste sample may optionally be diluted with a diluent, such as the diluent provided with the 7mm « «oCard®STAT! Kit, upon removal of the absorbent article from the wearer or application of the fluid/waste sample to the biosensors 12.
  • the results from the biosensors 12 may be read approximately 10 minutes after insult by a female wearer's fluids or waste or, if diluent was added, 10 minutes after the sample dilution.
  • the biosensors of the present invention may also comprise bio-recognition systems, including enzymes or binding proteins such as antibodies immobilized onto the surface of physico-chemical transducers.
  • a specific strain of bacteria may be detected via biosensors employing antibodies raised against that bacterial strain.
  • a target bacteria may be detected by a bio-recognition element (including antibodies and synthetic or natural molecular receptors) specific to extracellular products of the target bacteria, such as toxins produced by that strain (e.g., E. coli).
  • Exemplary enzyme electrodes that may be used to detect phenols (e.g. in urine) include tyrosinase based electrodes or polyphenol oxidase enzyme electrodes described in U.S. Patent No.
  • the specific microorganism may be directly detected or may be detected by binding a toxin, enzyme, or other protein produced by the organism or an antibody, such as a monoclonal antibody, specific to the organism.
  • the biosensor may be adapted to detect various specific types of bacteria that may be the cause of bacterial vaginosis, including Gardnerella vaginalis, Prevotella bivia, Bacteroides species, Mycoplasma hominis, Mobiluncus species.
  • the biosensor may be adapted to detect non-specific types of bacteria that may be the cause of bacterial vaginosis.
  • the biosensor may also be adapted to detect fungi such as Candida species, which is the cause of yeast vaginitis (or yeast infections).
  • the biosensor may also be adapted to detect protozoa such as Trichomonas vaginalis, which is the cause of Trichomoniasis, a non-reportable sexually transmitted disease, Chlamydia, or other sexually-transmitted diseases.
  • protozoa such as Trichomonas vaginalis
  • a non-limiting example of a commercially available biosensors adapted to detect G. vaginalis is the FEM EXAM® G. vaginalis PIP Activity TestCard available from Litmus Concepts, Inc. of Santa Clara, CA.
  • the FEM EXAM® G. vaginalis TestCard is described in U.S. Patent No. 5,571,684.
  • a non-limiting example of a commercially available biosensors adapted to detect non-specific causes of bacterial vaginosis is the FEM EXAM® pH and Amines TestCard available from Litmus Concepts, Inc.
  • the FEM EXAM® pH and Amines TestCard is described in U.S. Patent No. 5,660,790.
  • Other Litmus Concepts patents and patent publications of interest include: 5,268,146; 5,416,003; 5,585,273; 5,897,834; and PCT Publication WO 94/24306.
  • Non- limiting examples of biosensor adapted to detect Candida and Chlamydia are described in U.S. Patent Nos. 5,741,662 and 5,773,234, respectively, issued to Quidel Corporation of San Diego, CA.
  • the diagnostic panel may comprise biosensors adapted to detect at least two of the following group of bacteria: various types of bacteria that may be the cause of bacterial vaginosis, including Gardnerella vaginalis, Prevotella bivia, Bacteroides species, Mycoplasma hominis, Mobiluncus species.
  • Fig. 1 shows a non-limiting panty liner embodiment 920 containing an exemplary diagnostic panel 960 for detecting the various causes of vaginitis.
  • the diagnostic panel 960 shown in Fig. 1 contains five sensor elements, 962, 964, 966, 968, and 970. Each of these sensor elements is adapted to detect one or more of the causes of vaginitis alone, or in combination with one or more of the other sensor elements.
  • Sensor element 962 is adapted to detect pH.
  • Sensor element 964 is adapted to detect the presence of amines.
  • Sensor element 966 is adapted to detect G. vaginalis.
  • Sensor element 968 is adapted to detect Candida species.
  • Sensor element 970 is adapted to detect Trichomonas vaginalis.
  • the combination of sensor elements 962 and 964 can be used to detect nonspecific causes of bacterial vaginosis.
  • An early study of bacterial vaginosis (BV) involved comparisons of the pH of vaginal fluids of women known to be suffering from BV with those known to be free of the disease - Gardner, H.L., et al., Am. J. Obstet. Gynecol. 69: 962 (1955). All of the BV positive women in the study were determined to have a vaginal fluid pH greater than 4.5, and 91% of these women had a vaginal fluid pH greater than 5.0. Studies subsequent have now adjusted the pH threshold to 4.7.
  • the whiff test which is one of the Amsel criteria, originated in a study by Pheifer, et al., N. Ensl. J. Med. 298: 1429-1434 (1978), that reported the presence of a characteristic fishy amine odor upon the addition of 10% KOH to a vaginal fluid specimen from a woman with BV.
  • the odor is caused by the alkaline volatilization of amine salts found in the vaginal fluid of women with BV.
  • An example is a test device for analyzing an aqueous liquid sample (usually a biological specimen) for a pH equal to or greater than a critical point in the range of 4.6 to 4.8 (preferably about 4.7) by a detectable transition.
  • a further example is a test device for detecting salts of volatile amines in an aqueous liquid sample (again, usually a biological specimen).
  • This device contains a dry, solid gaseous amine-releasing substance in addition to an amine indicator retained in a matrix that is impermeable to aqueous liquids.
  • Preferred pH indicators are bromophenol blue, bromochlorophenol blue, bromocresol green, bromocresol purple, bromothymol blue, brilliant yellow, and nitrazine yellow.
  • a particularly preferred pH indicator is nitrazine yellow which, when in combination with quaternary ammonium groups, changes directly from greenish-yellow to blue over a narrow pH range of approximately 0.1 pH units as the pH rises, the transition centering around pH 4.7.
  • the quaternary ammonium groups can be any groups capable of asserting a positive charge sufficient to form an ionic attraction with the negatively charged group(s) in the indicator.
  • Preferred quaternary ammonium groups are lower alkyl ammonium groups in which the alkyl groups are C* - C alkyl groups. Trimethylammonium groups are particularly preferred.
  • the amine test differentiates between amines volatilized by alkali and those that are not volatilized by alkali by incorporating solid alkali accessible to the specimen, an indicator accessible to a liquid specimen, and an indicator accessible only to vapors emitted by the specimen, in the same device.
  • the specimen is first contacted with the solid alkali, then applied to both indicators, one of which sill undergo a color change regardless of the presence or absence of volatile amines, and the other a color change only in the presence of volatile amines.
  • the choice of solid alkali for the gas-releasing lamina is not critical and can vary. In general, alkali and alkaline earth metal aluminates, carbonates and hydroxides can be used. Best results will most often be achieved with the use of either sodium aluminate, sodium carbonate, or magnesium hydroxide. Sodium aluminate is particularly preferred.
  • Bromocresol green is one example, and may be used here as well as in the pH test.
  • Other examples are bromophenol blue, bromocresol purple, bromochlorophenol blue, nitrazine yellow, and various other indicators.
  • Sensor elements 962 and 964 can comprise the hereinbefore mentioned FEM EXAM® pH and Amines TestCard sensors available from Litmus Concepts, Inc. to detect non-specific causes of bacterial vaginosis.
  • Sensor element 966 is adapted to detect G vaginalis.
  • bacterial enzyme activity specifically proline iminopeptidase activity
  • vaginal fluid may be a suitable marker for BV.
  • the assay is performed by contacting the sample with a solid-phase conjugate which is susceptible to cleavage by the hydrolase, and either during or subsequent thereto, contacting the sample with an indicator which undergoes a detectable change upon the action of a reporter group which is a portion of the conjugate and is liberated from it either partly or entirely by the action of the hydrolase.
  • conjugate is used herein to refer to a reporter group coupled to a substrate residue yet capable of cleavage or decoupling therefrom upon contact with the catalytically active hydrolase whose presence is being detected.
  • reporter group or (interchangeably) “marker group” is used herein to refer to a moiety which can be hydrolytically released from the substrate residue by a hydrolase and which, in its free form, can react with an indicator to produce a detectable change.
  • reporter groups include, but are not limited to, the following: phenols, naphthols, aromatic amines, amino acids, their derivatives and analogs. In a particularly preferred embodiment, naphthylamine, its derivatives or analogs are used as the reporter group.
  • the hydrolase of interest hydrolyzes the conjugate at any other point other than freeing the reporter group, the hydrolase by itself would be incapable of releasing the reporter group in active form.
  • One or more assisting hydrolases which could only act in conjunction with the hydrolase of interest could then be incorporated into the assay to complete the release of the reporter group in active form.
  • the assisting hydrolase or hydrolases must therefore be ones which are incapable of releasing the reporter group directly from the intact conjugate, but instead capable of releasing the reporter group only from the cleavage product generated by the hydrolase of interest.
  • the hydrolase of interest unable to release the reporter group directly, specifically hydrolyzes one or more bonds in the conjugate, thereby releasing a molecular fragment containing the inactive reporter group.
  • the assisting hydrolase or hydrolases releases the reporter group by hydrolyzing the bond between the substrate residue fragment and the reporter group in one or more steps.
  • the net effect of the foregoing reaction sequence is the release of the reporter group only when the hydrolase of interest is present in the sample.
  • the sample is placed in a device which contains first and second solid supports, the first solid support being a Mylar® polyethylene laminate on which an L-prolyl-beta-naphthylamide, L-prolyl-beta-methoxynaphthylamide of hydroxy-L-prolyl- beta-naphthylamide conjugate is deposited, the second solid support being a Mylar® polyethylene laminate on which Fast Garnet GBC, a chromogenic indicator which undergoes a detectable change upon action of beta-naphthylamine, is deposited.
  • first solid support being a Mylar® polyethylene laminate on which an L-prolyl-beta-naphthylamide, L-prolyl-beta-methoxynaphthylamide of hydroxy-L-prolyl- beta-naphthylamide conjugate is deposited
  • the second solid support being a Mylar® polyethylene laminate
  • the sample is placed in the device in such a manner that the sample contacts the first and second solid supports such that any beta-naphthylamine released by proline iminopeptidase activity in the sample is permitted to diffuse through the sample to the second solid support.
  • the Fast Garnet GBC is then observed for a detectable change as an indication of the presence of the enzyme in the sample.
  • the conjugate may be incorporated in a matrix of water-soluble polymer such as hydroxypropyl cellulose.
  • the Fast Garnet GBC indicator may be incorporated in a water-insoluble matrix of ethylcellulose which contains a penetrant such as manganese chloride.
  • Sensor element 966 can comprise the hereinbefore mentioned FEM EXAM® G. vaginalis PLP Activity TestCard available from Litmus Concepts, Inc.
  • Sensor element 968 is adapted to detect Candida species. It has been discovered that enzymatically active Candida albicans aspartic protease is present in the vaginal fluid of women with vulvovaginal candidiasis. It has further been discovered that the presence of enzymatically active aspartic protease in a sample or specimen can serve as a marker for the detection and diagnosis of candidiasis. Accordingly, a method has now been developed for detecting candidiasis by assaying for the presence of enzymatically active aspartic protease in a sample.
  • a sample e.g., vaginal fluid
  • the solid support with which the sample is contacted has a reporter enzyme (i.e., a signal generating enzyme) immobilized thereon.
  • the reporter enzyme is immobilized on the solid support in a manner such that it is released from the solid support upon action of the enzymatically active aspartic protease if the enzymatically active aspartic protease is, in fact, present in the sample.
  • the sample after having been contacted with the solid support is combined with an indicator.
  • the indicator is any chemical species which is susceptible to a visible or detectable change (such as, for example, a change in color) upon action of the reporter enzyme. If after contact with the sample the indicator undergoes a detectable change, enzymatically active aspartic protease is present in the sample and, hence, it can be said that candidiasis is present.
  • reporter enzyme or (interchangeably) "marker enzyme” is used herein to refer to a signal generating enzyme, i.e., an enzyme whose activity brings about a detectable change.
  • reporter enzymes include, but are not limited to, the following: peroxidases, phosphatases, oxidoreductases, dehydrogenases, transferases, isomerases, kinases, reductases, deaminases, catalases, urease, and glucuronidase.
  • reporter enzymes are the peroxidases, such as, for example, horseradish peroxidase.
  • the reporter enzyme is immobilized on a solid support, i.e., an insoluble polymeric material, inorganic or organic matrix, gel, aggregate, precipitate or resin, in such a manner whereby the reporter enzyme is released upon action of the hydrolase whose presence is being assayed.
  • a solid support i.e., an insoluble polymeric material, inorganic or organic matrix, gel, aggregate, precipitate or resin
  • Preferred solid supports in accordance with the present invention include, but are not limited to, the following: cellulose, agarose, dextran, polyacrylate, polyacrylamide, or their derivatives, chitin, sepharose, oxirane acrylic beads and polymeric dialdehyde, starch, collagen, keratin, elastin, bovine hide powder, bacterial cell wall peptidoglycan or fragments thereof, nylon, polyethylene terephthalates, polycarbonates, and controlled pore glass. Immobilization of the reporter enzyme on the solid support is carded out using conventional methods and procedures known to and understood by those skilled in the art.
  • indicator is used herein to refer to any chemical species which undergoes a detectable change as a result of the reaction or as a result of the culmination of reactions occurring when the enzymatically active hydrolase is present in the sample or specimen.
  • the resulting detectable change is an indication that the enzymatically active hydrolase is present in the sample or specimen.
  • Preferred indicators are visual indicators and, in particular, chromogenic indicators, i.e., those in which the visible change is a change in color, including the formation of color in an otherwise colorless material, upon action of the reporter or marker enzyme when it is released from the solid support by the enzymatically active hydrolase whose presence is being detected.
  • the reporter enzyme may be capable of catalyzing the formation of a fluorescent signal, a phosphorescent signal, a bioluminescent signal, a chemiluminescent signal, or an electrochemical signal upon its release from the solid support by the action of the hydrolase.
  • the reporter enzyme may be capable of producing other visible or detectable signals, such as, for example, a clot, an agglutination, a precipitation, or a clearing zone.
  • chromogenic indicators i.e., chromogens
  • Preferred chromogenic indicators in accordance with the present invention comprise a hydroperoxide and a chromogen including, but not limited to, one of the following: guaiac, 2-2'-azino-bis(3-ethyl-benthiazoline-6-sulfonic acid), tetramethylbenzidine, phenol, 4-aminoantipyrine, and 4, 5-dihydroxynaphthatlene-2, 7- disulfonic acid.
  • a particularly preferred chromogenic indicator is comprised of a hydroperoxide and guaiac, a chromogen which is colorless in its reduced state and deep blue in its oxidized state.
  • Sensor element 970 is adapted to detect Trichomonas vaginalis.
  • a method for detecting Trichomonas vaginalis by assaying for the presence of enzymatically active thiol protease in a sample comprising: (a) contacting the sample with a solid support, the solid support having a reporter enzyme immobilized thereon in such a manner whereby the reporter enzyme is released upon action of the enzymatically active thiol protease; (b) combining the sample after having been contacted with the solid support with an indicator, the indicator being one which is susceptible to a detectable change upon action of the reporter enzyme; and (c) observing whether the indicator undergoes a detectable change, the detectable change being an indication of the presence of enzymatically active thiol protease in the sample and thus, Trichomonas vaginalis.
  • the panty liner 920 shown in Fig. 9 comprises a hybrid topsheet as described in U.S. Patent No. 6,004,893, Van Tilburg.
  • the sensor elements can be attached to the wearing- facing surface of the panty liner topsheet 924.
  • the sensors can be attached in the region of the panty liner corresponding to the location of the wearer's vagina.
  • the sensors can be attached via any attachment or bonding means as known in the art, such as an adhesive.
  • the topsheet may comprise at least one aperture and the sensors may be attached to the region of the underlying absorbent core corresponding to the topsheet aperture(s).
  • the sensor elements may be in the nature of a plus or minus sign to indicate the presence or absence of the test analytes in a quantity above a certain threshold as shown in Figs. 1 and 1 A.
  • they may be adapted to provide a colorimetric indication of the quantity of test analytes as shown in Fig. 3, and the darkness of the color on the sensor elements can be compared with a comparison chart, such as that shown in Fig. 4, which indicates the level of test analytes present.
  • the comparison chart can be provided in a number of suitable formats, including, but not limited to, in the form of a card that is packaged with the article on which the sensors are located, or on the outside of the package.
  • the sensor elements can be covered by a covering to prevent the test reagents in the sensors from coming in contact with the wearer's body, if test reagents are present.
  • the covering is clear and also flexible, so that it will not interfere with wearing the article, if the article is of a type to be worn adjacent to a wearer's body.
  • the covering can be made of any suitable material, such as plastic, SARAN® wrap, MYLAR®, or the like.
  • the covering can be apertured to allow body fluids to come into contact with the sensors, or it may be unapertured.
  • a covering it may be desirable to provide a fluid transport element, such as a wicking strip, underneath and/or on the sides of the sensors to bring the bodily fluids of interest into contact with the sensors.
  • a fluid transport element such as a wicking strip
  • Fig. 2 shows a non-limiting sanitary napkin embodiment 1220 containing an exemplary diagnostic panel 1260.
  • Figs. 7-9 show a non-limiting interlabial device embodiment 1320 containing an exemplary diagnostic panel 1360.
  • Fig. 10 shows how the interlabial device 1320 may be held by a user for insertion into the space between the wearer's labia.
  • Fig. 11 shows the interlabial device in place relative to the wearer's body.
  • Fig. 5 shows a non-limiting tampon embodiment 1620 containing an exemplary diagnostic panel 1660.
  • the biosensor used in the present invention may comprise one or more "proactive sensors". This is especially useful in embodiments where the detection of the target biologically reactive analyte precedes the onset of clinically observable health symptoms.
  • the term “proactive sensor” refers to a sensor that is capable of detecting changes or signals on the body of the wearer (i.e., skin) or in the waste, i.e., inputs, that directly relate or, at a minimum, correlate to the occurrence of an impending or potential health or skin related even.
  • Proactive sensors may respond to one or more specific inputs as described above.
  • a proactive sensor may detect an impending event or detect a parameter that directly relates, or at a minimum correlates to the occurrence of an impending event, particularly a systemic or skin health event or condition (i.e., the presentation of clinically observable indications or symptoms).
  • An impending event that may be detected or predicted by a proactive sensor of the present invention may include diarrheal disease, skin irritation or rash (including candidiasis), and/or other types of illness or medical conditions of the wearer such as a parasitic infestation.
  • the detected biological analyte may be one or more steps removed from the actual presentation of clinical symptoms.
  • the biosensor may detect potential precursors to the above conditions (e.g., fecal contamination of the skin that may precede the elicitation of stress proteins which may, in turn, precede clinically observable skin irritation.
  • a parameter that correlates to an event is any measurable input, signal such as one or more of the potential inputs listed above, that correlates with the occurrence of the event within the frame of reference of the system (i.e., a signal caused by the waste or the wearer).
  • Proactive sensors in an article may measure one or more different inputs in order to predict an event.
  • the proactive sensor may monitor for Candida albicans in the feces and residual colonic bacteria on the skin (i.e., detecting residual contamination) both of which are signals that may precede skin irritation.
  • the biosensor may include a transducer in communication with the bio-recognition element in order to convert the physico chemical signal from the bio-recognition element into a usable signal to the wearer, caretaker, or component of the article (e.g., and actuator).
  • exemplary transducers may include electrochemical transducers (including potentiometric, amperometric, and conductimetric transducers), optical transducers (including flourescence, bioluminesence, total internal reflective resonance, and surface plasmon resonance), thermal transducers, and acoustic transducers, as known in the art.
  • a power source such as a miniature 3 volt watch battery or printed thin film lithium battery, may be connected with the biosensor 60 to provide any required power.
  • the effectiveness of the biosensors of the present invention may be measured with the Response Factor Test described in the Test Method section below.
  • the Response Factor describes the ratio of the response of the biosensor when exposed to fluid/waste test material compared to the response of the biosensor when exposed to physiological saline solution and is useful in assessing the sensitivity of the biosensor for biologically active analytes expected to be found.
  • the biosensors of the present invention preferably have a response factor of at least 2, 3, or 5, more preferably at least 10, and even more preferably at least 20.
  • microorganisms are incorporated into a biosensor, they may be immobilized in the biosensor by techniques known in the art such as entrapment, adsorption, crosslinking, encapsulation, covalent attachment, any combination thereof, or the like. Further, the immobilization can be carried out on many different substrates such as known the art. In certain preferred embodiments, the immobilization substrate may be selected from the group of polymer based materials, hydrogels, tissues, nonwoven materials, woven materials.
  • the biosensor may comprise, be disposed on, or be operatively associated with a microchip, such as a silicon chip, MEMs (i.e., micro electromechanical system) device, or an integrated circuit.
  • a microchip such as a silicon chip, MEMs (i.e., micro electromechanical system) device, or an integrated circuit.
  • MEMs i.e., micro electromechanical system
  • the microchip may comprise a multiplicity of sensor components having similar or different sensitivities, kinetics, and/or target analytes (i.e., markers) in an array adapted to detect differing levels or combinations of said analyte(s).
  • each biosensor in such an array may provide a different type of signal, including those types disclosed herein, and may be associated with different actuators and/or controllers.
  • each biosensor in an array may operate independently or in association with (e.g., in parallel, combination, or series) any number of other sensors in the array.
  • the biosensor may be disposed in and/or operatively connected to any portion of an absorbent article that will be exposed to the input that the biosensor is designed to detect.
  • the term "operatively connected” refers to a means of communication such that the biosensor may signal some portion of the article 10 when the biosensor detects an input.
  • the biosensor may be separate from and operatively connected to another portion of the biosensor, another biosensor, an actuator, a controller or some other portion or component of the absorbent article 10.
  • "Operatively connected” may, for example, include a means of communication such as an electrical connection via a conductive wire or member, via a transmitted signal such as radio frequency, infrared or another transmitted frequency communication.
  • the biosensor may be operatively connected via a mechanical connection such as a pneumatic or a hydraulic connection.
  • the biosensor may be integral with the absorbent article 10, or may be installed by the caretaker or the wearer.
  • the biosensor during the course of wearing the article may also become at least partially detached from the article and may be adhered to the wearer's skin.
  • the biosensor may be affixed, permanently or detachably (e.g., via a mechanical fastening system like VelcroTM or a water soluble adhesive) to a support structure, including adhesive tapes, cellulosic or synthetic webs, nonwoven highlofts, films, scrims, foams, and the like.
  • the biosensor may be completely contained within the absorbent article 10 or may have a receiving portion located in the absorbent article 10 such that it will come into contact with the desired input and another portion such as a transmitting portion located either in the article or outside the article.
  • the biosensor may be external to the absorbent article 10 yet operatively connected to some portion of the absorbent article 10 such that the biosensor may detect an input external to the absorbent article 10 and provide a signal to a controller and/or an actuator.
  • the biosensor may be separate from the article, e.g., separately applied to some portion of the wearer via adhesive or other means as known in the art, and/or may have one or more components separate from the article.
  • a wiping means or element may be provided to allow the wearer or caretaker to clean sufficient bodily waste from the biosensor to allow a visual assessment or reading of the signal (especially for biosensor embodiments that provide such a signal).
  • the wiping element may include a web (cellulosic or synthetic), nonwoven highloft, film, foam, rigid or semi-rigid squeegee like element, and the like disposed in the article and adapted such that the element may be used to clean the biosensor display.
  • the wiping element may be at least partially affixed to an element (e.g., topsheet, backsheet, absorbent core) of the article, such as a topsheet, in proximity to the biosensor by any known means in the art.
  • the wiping means may optionally comprise water or any other known cleaning aid to facilitate cleaning of the wearer or the biosensor display.
  • the absorbent article 10 also may comprise an actuator.
  • the term "actuator” refers to a device that comprises “potential” and a means of transforming that potential to perform or activate a "responsive function.”
  • the potential of the actuator may comprise either stored or potential energy or stored material.
  • the actuator thus may perform or activate a responsive function by transforming potential energy to kinetic energy or by releasing or delivering a stored material.
  • a "responsive function” is defined for the purposes of the present invention as a function performed upon the bodily waste, the wearer, the article, or a component or components thereof, or a signal to the wearer or the caretaker.
  • a component of bodily waste may include, for example, moisture, electrolytes, enzymes, volatile gases, bacteria, blood, etc.
  • a component of the wearer may also include skin, genitalia, the pudendal region, the anus, the anal sphincter muscle, etc.
  • a component of the article may also include leg cuffs, waist cuffs or other waste barriers and/or containment components, side panels, ears, a chassis, an absorbent core, an acquisition component, a fastening system, the longitudinal or end edges, etc.
  • Potential energy may be stored as mechanical, electrical, chemical or thermal energy.
  • Keetic energy refers to the capacity to do work or to perform a responsive function as described above (e.g., expansion of a compressed device, rotation of a twisted device, a gel that moves as it changes phases, coating or treatment of skin, inhibition of an enzyme, adjustment of pH, etc.).
  • the absorbent article 10 may also include a controller.
  • a "controller” is defined for the purposes of this application as a device that receives an input from a biosensor and determines if one or more actions are to be taken.
  • the controller may receive a signal from the biosensor and direct the actuator to perform a responsive function upon the bodily waste, the wearer, the article or a component thereof.
  • the actuator may receive the signal directly from the biosensor and perform a responsive function upon the wearer, the waste, the article or a component thereof.
  • the controller may include materials that undergo chemical or physical change, may be a chemical, mechanical or electrical device that processes information from a biosensor, etc.
  • the controller may include a transducer comprising a polylayer Langmuir-Blodgett film, wherein one or more layers includes a bio-recognition element.
  • a transducer comprising a polylayer Langmuir-Blodgett film, wherein one or more layers includes a bio-recognition element.
  • Langmuir-Blodgett films Upon contact with water, Langmuir-Blodgett films are known to spontaneously reorganize, resulting in regions with more layers than the original film and other regions having fewer layers. This reorganization may expose the bio-recognition element to the environment preferentially in the presence of water, such as in bodily waste, which may contain the target biological analyte.
  • an electrical controller that receives signals such as electrical potential from an electrochemical biosensor may receive and monitor multiple electrical signals and may repeatedly trigger the actuator.
  • the controller may be integral with the biosensor component, integral with the actuator component, or a
  • the controller may be disposed in and/or operatively connected to any portion of a disposable article that will allow the controller to receive a signal from the biosensor and to provide a signal to the actuator.
  • the controller may be integral with the absorbent article 10, or may be installed by the caretaker or the wearer.
  • the controller may be completely contained within the article such as absorbent article 10, may have a portion located in the article and a portion located outside the article, or may be located completely outside the absorbent article 10.
  • the controller or a portion of a controller may be operatively connected to one or more biosensors, one or more actuators 90, another portion of the controller or another portion of the absorbent article 10.
  • the controller for example, may receive a signal from the biosensor and provide a signal to the actuator, e.g., by a radio frequency (rf) transmission.
  • rf radio frequency
  • biosensor, actuator and controller functions may perform the biosensor, actuator and controller functions
  • biosensor, actuator and/or controller functions of the present invention need not be performed by distinct structural elements.
  • the biosensor and controller functions, for example, may be performed by the same structural element.
  • a "responsive system” is defined for the purposes of this application as a system that includes a biosensor and an actuator that acts upon the bodily waste, the wearer, the article, or a component or components thereof when the biosensor detects the appropriate triggering input.
  • the actuator Upon sensing a given input parameter, the actuator effects the release of stored energy or the release or delivery of stored material to perform a responsive function.
  • a proactive biosensor including a transducer detects an impending event
  • the transducer provides a signal to the actuator effecting the release of stored energy.
  • a responsive system in the article may be triggered to prepare for the event or to signal the caregiver or the wearer of the impending event.
  • the waste-management or treating technology is initially "hidden” or unobtrusive, but which is available at, or just before, the moment of need and/or in which the article may provide the caregiver or the wearer the opportunity to prepare for an event in advance (e.g., administer a prohylactic treatment to the wearer in the event of detected pathogenic microorganisms).
  • the biosensor in these embodiments may trigger an actuator to perform an action on the article, the wearer or the environment to prepare for the occurrence of the event or provide a signal to the caregiver that the impending event is about to occur.
  • one actuator may be triggered by different biosensors and/or signals, or different actuators may be triggered by different biosensors and/or signals. Alternatively, one biosensor and/or signal may trigger multiple actuators.
  • a responsive system may respond in either a “continuous” or a “discontinuous” manner.
  • a “continuous responsive system” refers to a responsive system in which the output is quantitatively dependent upon the quantity of the input, i.e., continuously increasing quantities of the input are required to effect continuously increasing quantities of the output, or where the output of the responsive system comprises a passive release of a stored material.
  • a super absorbent polymer placed in an absorbent core of an article provides a continuous response in which the output is quantitatively dependent upon the quantity of the input, i.e., as increasing quantities of liquid waste contact the super absorbent polymer, an increasing amount of the polymer contains that liquid until the capacity of the polymer is exhausted.
  • a stoichiometric chemical reaction is another example of a system having a continuous response to increasing output. In the reaction A + excess B *- C, for example, the amount of excess B converted to C is stoichiometrically and, therefore "continuously,” related to the amount of A available in the system.
  • a “discontinuous responsive system” of the present invention refers to a responsive system that has an output function that is essentially independent of the quantity of the input beyond a threshold level. For example, when one or more threshold levels of a given input are met, the responsive system may release all or a pre-designated portion of its stored energy or deliver, i.e., actively transport, all or a pre-designated portion of its stored material to perform a specific responsive function.
  • the output function, f(x) includes a "step" function as shown in Figure 3A.
  • the rate of change in the output with increasing levels of input d(output)/d(input)
  • the slope or first derivative f (x) of the output function f(x) is preferably essentially zero when the amount of input is above or below the threshold level.
  • the d(output)/ d(input) rate of change preferably approaches infinity.
  • the limit of the function f(x- ⁇ ) as ⁇ O is not equal to the limit of the function f(x+ ⁇ ) as ⁇ -»0, i.e., lim f(x- ⁇ ) ⁇ lim f(x+ ⁇ ).
  • the present invention recognizes that in the physical world an ideal instantaneous step change at the threshold level is not necessary and may not even be possible in many instances. In a preferred embodiment, it is only necessary that the output function have a virtual step change with very little change in the input at or around the threshold level of the input. Thus, the present invention contemplates a discontinuous responsive system of the present invention having an output function that responds in a sufficiently discontinuous manner in the transition region such that the output function has at least a minimum relative degree of steepness in the transition region.
  • the slope of the output curve at the inflection point is compared with the relative slope of a line between the first and last points of the transition region.
  • Figure 4A shows a graph of an exemplary output function, f(x) along with aligned graphs of the first, f (x), and second, f '(x), and third, f "(x), derivatives of the exemplary output function.
  • the output function f(x) describes the effect of the in put (x or I) on the output or response (R(I)).
  • the transition region is defined as the region between the relative maxima, R(I ⁇ ), and the minima, R(I 2 ), of the second derivative, f '(x), of the output function, f(x).
  • the relative maxima, R(I ⁇ ), and the relative minima, R(I 2 ), are points at which the third derivative, f "(x), equals zero.
  • the inflection point, In is defined as the point in the transition region at which the second derivative, f '(x), equals zero, i.e., d 2 R I
  • dR/dl at the inflection point is the first derivative of the output function at that point.
  • ⁇ I ⁇ is the change in the input to the responsive system between the first, I- . , and last, I , points of the transition region, i.e., I 2 - I ⁇
  • ⁇ R is the change in the response of the output function between the first and last points of the transition region, i.e., R(I 2 ) - R(I ⁇ ).
  • the coefficient k is a proportional constant that describes the relative steepness of the slope of the output function at the inflection point, Io, compared to the slope of a line between the first and last points of the transition region.
  • the proportional constant k must be at least about 2.0, preferably at least about 3.0, more preferably at least about 5.0, even more preferably at least about 10.0, with at least about 100.0 being the most preferred.
  • the relative degree of steepness in the transition region of a discontinuous responsive system may also be modeled by a transfer function of a control system having a series of an integer number, n, first order lags with an equal time constant.
  • the transfer function of the responsive system is defined for the purposes of the present invention as the ratio of the Laplace transforms of the output (responding variable) to the input (disturbing variable). See, e.g., Robert H. Perry & Don Green, Perry's Chemical Engineers' Handbook. Sixth Ed., Chap. 22 (McGraw Hill, Inc. 1984).
  • KG(s) K/(Ts + l) n in which KG(s) is the transfer function, K is a proportional element, T is the time constant of the system, and n is the integer number of first order time lags.
  • K is a proportional element
  • T the time constant of the system
  • n the integer number of first order time lags.
  • Certain discontinuous responsive systems of the present invention preferably may be modeled by the above formula when n is greater than or equal to about 25, with n being greater than or equal to about 50 being more preferred, and n being greater than or equal to about 100 being the most preferred.
  • a responsive system of the present invention may include a single threshold level at which the responsive system may release all of its stored energy to perform a specific responsive function or may include multiple threshold levels at which the system may release a pre-designated portion of its stored energy to perform one or more specific responsive functions at each of the threshold levels.
  • the responsive system may release all of its stored energy to perform the entire responsive function when that threshold level is met.
  • the discontinuous responsive system includes a system that has two states such as on or off.
  • the responsive system may perform a single responsive function upon the waste, the wearer, the article or a component thereof, such as enveloping the waste away from the skin of the user or providing an easily detectable visual signal to the wearer or caregiver.
  • the discontinuous responsive system may perform a one-time "switch-like" function that changes from one state to another in the presence of a threshold level of an input.
  • the responsive system may have multiple threshold levels at which when each threshold level is met the system may release a given "quanta" of energy or deliver a given quantity of material to perform a specific responsive function.
  • a portion of the entire responsive function may be performed and/or different independent responsive functions may be performed in response to different threshold levels being met.
  • a responsive system may monitor a target enzyme and when each threshold enzyme level is met may deliver an equal or unequal quantity of enzyme inhibitor(s) or lotion, or deliver a pH buffer at the first threshold level and perform another responsive function such as delivering a quantity of enzyme inhibitor(s) at the second threshold level.
  • the responsive system responds essentially the same as the transition region in the single threshold embodiment described above.
  • a responsive system may monitor multiple inputs such as one or more pathogenic bacteria and/or one or more target enzymes and perform one or more responsive functions when the threshold levels of the different inputs are met or may perform one responsive function only when two or more of the threshold levels of the different inputs are met.
  • a controller may monitor multiple different inputs and perform a different responsive function when the threshold level of the different inputs are met.
  • the controller may perform a logic OR-gate type function such that a responsive function may be performed when one or more threshold levels of the multiple inputs are met.
  • the controller may also perform a logic AND-gate type function such that a responsive function may be performed when each threshold level of two or more different inputs is met.
  • the responsive system may also comprise a "closed loop” or an "open loop” system.
  • a "closed loop” system which is also referred to as a “feedback control loop” system, includes distinct biosensor and actuator components and performs a responsive function upon the input.
  • the system may also use a detection or a measurement of an element or a parameter of the output condition as at least one trigger of the responsive function that is performed upon the input.
  • the output condition may be the state of the input condition after the actuator has had the opportunity to perform a responsive function on the input condition.
  • the responsive function may be performed when the output condition reaches a threshold level, or may be performed only when the output condition and one or more other conditions are met.
  • Acting upon the input may include acting upon the element sensed, e.g., sensing a microorganism and acting upon the microorganism, or may include acting upon a composition of which the element sensed is an integral component.
  • a feedback control loop system includes at least two distinct components: the biosensor 60 and the actuator.
  • the biosensor detects an event, or a parameter associated with that event.
  • the actuator receives a signal and performs a responsive function on the input condition detected by the biosensor.
  • the feedback control loop may further include a controller.
  • the biosensor may provide a signal to the controller, and the controller may direct the actuator to perform a responsive function upon the input condition.
  • the controller may be a separate component of the responsive system or the controller function may be performed by the biosensor and/or the actuator.
  • the feedback control loop may be "non-modulating" or “modulating.”
  • a “non- modulating" feedback control loop responsive system the responsive system acts as a onetime switch in which the actuator performs a responsive function on the input when the threshold level of the output condition is met.
  • the biosensor may detect the presence of or measure the concentration of a specific pathogenic microorganism, and the actuator may signal the caretaker of a potential incipient infection.
  • the actuator acts upon the input detected by the biosensor.
  • a “modulating" feedback control loop includes a biosensor, an actuator and a controller.
  • the output condition is monitored constantly or repeatedly, and the controller directs the actuator to perform a responsive function on the input in order to maintain the output condition at a desired set point or within a desired range or to provide a continuous measurement of the level or concentration of the target biological analyte.
  • An "open loop" system is a system that responds to the input to perform a responsive function without using feedback, i.e., the output has no effect upon the sensed input entering the system.
  • An open loop system may include a responsive system that has a single device that performs the functions of both the biosensor and the actuator or may have distinct biosensor and actuator components in which the actuator acts upon something other than the input.
  • a super absorbent polymer placed in an absorbent core of a disposable absorbent article for example, provides an open loop response because the polymer only includes a single device that performs the functions of the biosensor and actuator.
  • an open loop responsive system may include a biosensor that detects bodily waste or a component of that bodily waste, and an actuator that performs a responsive function in a continuous or a discontinuous manner on something other than the input detected by the biosensor.
  • the present invention includes responsive systems that provide a discontinuous or continuous response, whether open loop or closed loop.
  • Other responsive systems are described in United States Patent Application Numbers 09/106,424 entitled “Disposable Article Having A Discontinuous Responsive System” filed on June 29, 1998 (P&G Case Number 7197); 09/107,563 entitled “Disposable Article Having A Responsive System Including A Feedback Control Loop” filed on June 29, 1998 (P&G Case Number 7198); and 09/106,225 entitled “Disposable Article Having A Responsive System Including A Mechanical Actuator” filed on June 29, 1998 (P&G Case Number 7199), each of which is incorporated herein by reference.
  • the disclosures of all patents, as well as any corresponding published foreign patent applications), and publications mentioned throughout this patent application are hereby incorporated by reference herein. It is expressly not admitted, however, that any of the documents incorporated by reference herein teach or disclose the present invention.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Vascular Medicine (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Materials Engineering (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)

Abstract

L'invention porte sur un dispositif pour diagnostics multiples relatifs à la santé de la femme comportant un biodétecteur capable de détecter plusieurs analytes cibles présents dans des fluides corporels recueillis sur ou à travers la peau, et révélateurs de la santé de la femme. Lesdits fluides corporels consistent en sécrétions vaginales, règles, sang, urine et salive. Le biodétecteur comporte de préférence au moins un élément de reconnaissance de plusieurs analytes biologiques. Le dispositif pour diagnostics peut s'utiliser dans un ou plusieurs articles absorbants.
PCT/US2000/011207 1999-04-26 2000-04-26 Dispositif pour diagnostics multiples de la sante de la femme WO2000065347A2 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
CA002370739A CA2370739A1 (fr) 1999-04-26 2000-04-26 Dispositif pour diagnostics multiples de la sante de la femme
JP2000614036A JP2003517584A (ja) 1999-04-26 2000-04-26 女性の健康のための多重診断装置
EP00930160A EP1173758A2 (fr) 1999-04-26 2000-04-26 Dispositif pour diagnostics multiples de la sante de la femme
MXPA01010946A MXPA01010946A (es) 1999-04-26 2000-04-26 Dispositivo de diagnostico multiple para la salud de una mujer.
AU48029/00A AU4802900A (en) 1999-04-26 2000-04-26 Multiple diagnostic device for a woman's health

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US09/299,399 US6713660B1 (en) 1998-06-29 1999-04-26 Disposable article having a biosensor
US09/299,399 1999-04-26
US51748100A 2000-03-02 2000-03-02
US51744100A 2000-03-02 2000-03-02
US09/517,481 2000-03-02
US09/517,441 2000-03-02

Publications (3)

Publication Number Publication Date
WO2000065347A2 true WO2000065347A2 (fr) 2000-11-02
WO2000065347A3 WO2000065347A3 (fr) 2001-03-01
WO2000065347A9 WO2000065347A9 (fr) 2002-02-21

Family

ID=27404650

Family Applications (5)

Application Number Title Priority Date Filing Date
PCT/US2000/011204 WO2000065083A2 (fr) 1999-04-26 2000-04-26 Protections periodiques feminines jetables pourvues d'un moyen de detection du sang, en tant que capteur
PCT/US2000/011206 WO2000065096A1 (fr) 1999-04-26 2000-04-26 Protege-slip dote de capteur conçu pour predire le debut de la menstruation
PCT/US2000/011207 WO2000065347A2 (fr) 1999-04-26 2000-04-26 Dispositif pour diagnostics multiples de la sante de la femme
PCT/US2000/011208 WO2000065348A2 (fr) 1999-04-26 2000-04-26 Articles jetables et analogues comprenant un dispositif de detection
PCT/US2000/011205 WO2000065084A2 (fr) 1999-04-26 2000-04-26 Composition pour detection de sang

Family Applications Before (2)

Application Number Title Priority Date Filing Date
PCT/US2000/011204 WO2000065083A2 (fr) 1999-04-26 2000-04-26 Protections periodiques feminines jetables pourvues d'un moyen de detection du sang, en tant que capteur
PCT/US2000/011206 WO2000065096A1 (fr) 1999-04-26 2000-04-26 Protege-slip dote de capteur conçu pour predire le debut de la menstruation

Family Applications After (2)

Application Number Title Priority Date Filing Date
PCT/US2000/011208 WO2000065348A2 (fr) 1999-04-26 2000-04-26 Articles jetables et analogues comprenant un dispositif de detection
PCT/US2000/011205 WO2000065084A2 (fr) 1999-04-26 2000-04-26 Composition pour detection de sang

Country Status (8)

Country Link
EP (5) EP1173759A2 (fr)
JP (5) JP2002543397A (fr)
CN (2) CN1348501A (fr)
AU (5) AU4665900A (fr)
BR (2) BR0010059A (fr)
CA (5) CA2370502A1 (fr)
MX (5) MXPA01010948A (fr)
WO (5) WO2000065083A2 (fr)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002015863A1 (fr) * 2000-08-18 2002-02-28 Psimedica Limited Composition dermatologique
JP2002372527A (ja) * 2001-06-13 2002-12-26 Fujirebio Inc 経血又は膣分泌物採取器具、キット及び方法
WO2006046990A1 (fr) * 2004-10-22 2006-05-04 Kimberly-Clark Worldwide, Inc. Detection de la trichomonose
US7365238B2 (en) 2002-02-19 2008-04-29 The Procter And Gamble Company Absorbent article having a dehydration indicator
EP2172769A1 (fr) 2008-10-06 2010-04-07 Sony Corporation Détecteur pour analyses de thiol
US7994079B2 (en) 2002-12-17 2011-08-09 Kimberly-Clark Worldwide, Inc. Meltblown scrubbing product
US9034593B2 (en) 2010-11-22 2015-05-19 Kimberly-Clark Worldwide, Inc. Vaginal indicator to detect biomarkers of good health
US20160066894A1 (en) * 2014-03-21 2016-03-10 Razzberry Inc. Health state monitoring device

Families Citing this family (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7002054B2 (en) 2001-06-29 2006-02-21 The Procter & Gamble Company Absorbent article having a fever indicator
US6921647B2 (en) * 2001-07-19 2005-07-26 Common Sense Ltd. Secretion-monitoring article
JP4677597B2 (ja) 2001-08-31 2011-04-27 ユニ・チャーム株式会社 使い捨ておむつ
US9017963B2 (en) 2002-01-31 2015-04-28 Woundchek Laboratories (Us), Inc. Method for detecting microorganisms
DE10225943A1 (de) 2002-06-11 2004-01-08 Basf Ag Verfahren zur Herstellung von Estern von Polyalkoholen
US20040015145A1 (en) 2002-07-16 2004-01-22 The Procter & Gamble Company Absorbent article having a graphic visible through body contacting surface
DE10309349B4 (de) * 2003-03-03 2005-11-10 Micronas Holding Gmbh Vorrichtung zur Untersuchung eines Analyten
WO2004086043A1 (fr) * 2003-03-26 2004-10-07 Johnson & Johnson Medical Limited Prediction et detection d'une infection de plaie
FR2855824A1 (fr) * 2003-06-03 2004-12-10 Solvay Procede pour la fabrication d'un compose organique comprenant au moins un groupement fonctionnel oxygene
US7153561B2 (en) 2003-07-11 2006-12-26 Kimberly-Clark Wordwide, Inc. Absorbent article with graphic design thereon
JP2005192863A (ja) * 2004-01-08 2005-07-21 Sekisui Chem Co Ltd 出血検知シート
US7977529B2 (en) 2004-11-03 2011-07-12 Fred Bergman Healthcare Pty Ltd. Incontinence management system and diaper
CN100397080C (zh) * 2005-03-02 2008-06-25 金车股份有限公司 具有免疫层析检测指示功能的卫生用品
SG126797A1 (en) * 2005-05-04 2006-11-29 King Car Food Ind Co Ltd Sanitary utensil with functions of immuno-chromatographic test and indication
US20070128589A1 (en) * 2005-07-13 2007-06-07 Sanders Mitchell C Substrates, sensors, and methods for assessing conditions in females
WO2007076483A1 (fr) * 2005-12-22 2007-07-05 Hollister Incorporated Système de détection de paramètres physiologiques de point d'intervention
US20080086103A1 (en) 2006-10-04 2008-04-10 The Procter & Gamble Company Kit including an absorbent article
US8044257B2 (en) 2006-10-30 2011-10-25 Kimberly-Clark Worldwide, Inc. Absorbent article containing lateral flow assay device
US7846383B2 (en) 2006-12-15 2010-12-07 Kimberly-Clark Worldwide, Inc. Lateral flow assay device and absorbent article containing same
US20080269707A1 (en) * 2007-04-30 2008-10-30 Kimberly-Clark Worldwide, Inc. Lateral Flow Device for Attachment to an Absorbent Article
GB0722729D0 (en) 2007-11-20 2007-12-27 Bristol Myers Squibb Co Diagnostic markers of wound infection
US9103796B2 (en) * 2007-12-14 2015-08-11 Kimberly-Clark Worldwide, Inc. Multi-layered devices for analyte detection
JP5155003B2 (ja) * 2008-04-16 2013-02-27 花王株式会社 吸収性物品
US8101813B2 (en) 2008-10-30 2012-01-24 Kimberly-Clark Worldwide, Inc. Training progress indicator
EP2376040B2 (fr) 2009-01-15 2023-11-29 The Procter & Gamble Company Article absorbant a porter en deux pièces
US20100179502A1 (en) 2009-01-15 2010-07-15 Donald Carroll Roe Reusable Wearable Absorbent Articles With Anchoring Subsystems
JP5591826B2 (ja) 2009-01-15 2014-09-17 ザ プロクター アンド ギャンブル カンパニー 固定サブシステムを有する再利用可能な着用可能吸収性物品
US9387138B2 (en) 2009-01-15 2016-07-12 The Procter & Gamble Company Reusable outer covers for wearable absorbent articles
US8585667B2 (en) 2010-05-21 2013-11-19 The Procter & Gamble Company Insert with advantageous fastener configurations and end stiffness characteristics for two-piece wearable absorbent article
EP2595593A2 (fr) 2010-07-22 2013-05-29 The Procter and Gamble Company Revêtement extérieur pour un article absorbant
US20120022491A1 (en) 2010-07-22 2012-01-26 Donald Carroll Roe Flexible Reusable Outer Covers For Disposable Absorbent Inserts
USD656852S1 (en) 2010-08-06 2012-04-03 Kimberly-Clark Worldwide, Inc. Wetness indicator
US9018434B2 (en) 2010-08-06 2015-04-28 Kimberly-Clark Worldwide, Inc. Absorbent articles with intricate graphics
CN103299184A (zh) * 2010-10-29 2013-09-11 Atonarp株式会社 分析装置
US9220640B2 (en) 2010-12-30 2015-12-29 Kimberly-Clark Worldwide, Inc. Absorbent article including two dimensional code made from an active graphic
US9078792B2 (en) 2011-06-30 2015-07-14 The Procter & Gamble Company Two-piece wearable absorbent article having advantageous front waist region and landing zone configuration
US20130202499A1 (en) * 2012-01-31 2013-08-08 Kimberly-Clark Worldwide, Inc. Composition and Sensor for Detecting Occult Blood
JP5982920B2 (ja) * 2012-03-22 2016-08-31 王子ホールディングス株式会社 吸収性物品
US8932273B2 (en) 2012-06-29 2015-01-13 The Procter & Gamble Company Disposable absorbent insert for two-piece wearable absorbent article
JP6026822B2 (ja) * 2012-08-28 2016-11-16 花王株式会社 吸収性構造体及び吸収材
US9131893B2 (en) 2012-10-26 2015-09-15 Pixie Scientific, Llc Health diagnostic systems and methods
US9060905B2 (en) 2013-03-08 2015-06-23 The Procter & Gamble Company Wearable absorbent articles
US9078789B2 (en) 2013-03-08 2015-07-14 The Procter & Gamble Company Outer covers and disposable absorbent inserts for pants
US8936586B2 (en) 2013-03-08 2015-01-20 The Procter & Gamble Company Ergonomic grasping aids for reusable pull-on outer covers
US8926579B2 (en) 2013-03-08 2015-01-06 The Procter & Gamble Company Fastening zone configurations for outer covers of absorbent articles
US20150057632A1 (en) 2013-08-23 2015-02-26 The Procter & Gamble Company Absorbent Article
US9486368B2 (en) 2013-12-05 2016-11-08 Medline Industries, Inc. Disposable hygienic article with means for diagnostic testing
US9606116B2 (en) * 2014-05-11 2017-03-28 Lia Diagnostics, Inc. Flexible, integrated urine-based diagnostic service
CN109613177B (zh) 2014-07-01 2021-08-20 科蒙森斯公司 用于鉴定羊水的诊断组合物
WO2016028497A1 (fr) * 2014-08-21 2016-02-25 Naseri, Sara Système et procédé d'analyse non-invasive de fluides corporels
US10273463B2 (en) 2014-10-16 2019-04-30 International Paper Company Chemiluminescent wetness indicator for absorbent products
US10117790B2 (en) * 2015-02-26 2018-11-06 Johnson & Johnson Vision Care, Inc. Personal hygiene product with a digital element
CN104720829A (zh) * 2015-03-19 2015-06-24 御基集团有限公司 一种获取吸收性制品的反馈信息的方法、装置
US10383564B2 (en) 2015-05-22 2019-08-20 Pixie Scientific, Llc Indicator panels for incontinence products
WO2017010800A1 (fr) * 2015-07-13 2017-01-19 (주)룬랩 Coupe menstruelle intelligente et procédé de mesure de sang menstruel à l'aide de la coupe menstruelle intelligente
JP5916935B1 (ja) * 2015-11-05 2016-05-11 ユニ・チャーム株式会社 愛玩動物用の吸収性物品
EP3429477A4 (fr) 2016-03-18 2019-03-06 Qurasense, Inc. Dispositif de collecte pour le diagnostic de pertes vaginales
CN105832459B (zh) * 2016-03-21 2018-05-25 京东方科技集团股份有限公司 生理调节系统、智能内裤和生理调节方法
PL3435941T3 (pl) * 2016-03-30 2022-05-09 Convatec Technologies Inc. Wykrywanie infekcji drobnoustrojowych w ranach
KR101830701B1 (ko) * 2016-08-24 2018-02-22 장유리 피임과 임신에 용이한 여성용품
CN107981870A (zh) * 2016-10-27 2018-05-04 广州悦鸿方生物科技有限公司 一种卫生棉条
KR101960585B1 (ko) * 2017-01-19 2019-03-21 전자부품연구원 하이드로젤을 포함하는 부착형 화학 센서 및 그 제조방법
WO2018190527A1 (fr) * 2017-04-10 2018-10-18 주식회사 룬랩 Coupelle menstruelle ayant une cartouche de test sanguin
CN107149524A (zh) * 2017-05-14 2017-09-12 郭宝煊 智能卫生棉条
EP3435261A1 (fr) * 2017-07-28 2019-01-30 Bayer AG Prévision de cycle menstruel de la femme après l'introduction d'un système de libération de substance active intra-utérin
CN110221049A (zh) * 2018-03-01 2019-09-10 三六五（天津）软件科技有限公司 一种智能健康检测设备
CN108403297A (zh) * 2018-03-12 2018-08-17 南京理工大学 一种智能敷料及其制备方法
US11078200B2 (en) 2018-06-29 2021-08-03 International Paper Company Synthesis of coelenterazine
JP2021531241A (ja) 2018-06-29 2021-11-18 インターナショナル・ペーパー・カンパニー セレンテラジンの合成
KR102300084B1 (ko) * 2019-11-20 2021-09-08 주식회사 더로드 질병 검출용 직조물 및 이를 이용한 생리용품
WO2021132724A1 (fr) * 2019-12-27 2021-07-01 ユニ・チャーム株式会社 Article absorbant et emballage pour article absorbant
KR102241058B1 (ko) * 2020-03-23 2021-04-16 전남대학교산학협력단 패드형 여성 성기능 진단기구
CN111772682B (zh) * 2020-07-10 2021-08-13 北京大学第三医院（北京大学第三临床医学院） 预测受试者出现卵巢储备新变化年限的系统和方法
CN112710653B (zh) * 2020-12-10 2024-08-30 达州职业技术学院 一种快速检测潜在血渍的专用试剂及其制备方法
GB2616873B (en) 2022-03-23 2024-05-22 Ide8 Ltd Superabsorbent Polymer based Biosensor Apparatus and Methods
WO2024084726A1 (fr) * 2022-10-21 2024-04-25 ユニ・チャーム株式会社 Article absorbant avec bandelette réactive pour décharge vaginale, et bandelette réactive pour décharge vaginale destinée à être utilisée dans un article absorbant
JP2024061668A (ja) * 2022-10-21 2024-05-07 ユニ・チャーム株式会社 おりもの用テストストリップ
WO2024176657A1 (fr) * 2023-02-22 2024-08-29 テルモ株式会社 Dispositif de mesure de composant et procédé de mesure de composant

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994024557A1 (fr) * 1993-04-16 1994-10-27 The United States Of America, As Represented By Th Article et procede permettant de detecter la presence de germes pathogenes dans des matieres fecales
US5468236A (en) * 1993-06-09 1995-11-21 Kimberly-Clark Corporation Disposable absorbent product incorporating chemically reactive substance
WO1999002985A1 (fr) * 1997-07-11 1999-01-21 Rosengreen Lea T Dispositif portable permettant de detecter du liquide amniotique
WO2000000233A1 (fr) * 1998-06-29 2000-01-06 The Procter & Gamble Company Article jetable avec detecteur de dejections

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1980002596A1 (fr) * 1979-05-16 1980-11-27 G Oster Procede de determination d'une ovulation imminente
US4231370A (en) * 1979-06-18 1980-11-04 The Procter & Gamble Company Disposable diaper type garment having wetness indicator
DE3231288C2 (de) * 1982-08-23 1984-06-28 MEDI-PHARMA Vertriebsgesellschaft mbH, 5000 Köln Diagnostische Vorrichtung und ihre Verwendung
GB8505899D0 (en) * 1985-03-07 1985-04-11 Boots Celltech Diagnostics Assay reagents
GB2208712B (en) * 1985-03-07 1989-07-05 Boots Celltech Diagnostics Improvements relating to assay reagents
IL84443A (en) * 1987-11-11 1993-01-14 Schoenfeld A Vaginal tampon
US5823953A (en) * 1996-06-20 1998-10-20 Roskin; Amy C. Secretion analysis apparatus and method
US5792618A (en) * 1996-09-27 1998-08-11 Moss, Inc. Liquid single-component substrates for detection or assay of horseradish peroxidase
BR9605451A (pt) * 1996-10-25 1998-08-04 Barreto Leonardo Claudian Paes Conjugado absorvente indicador
JP2927772B2 (ja) * 1998-03-09 1999-07-28 株式会社大貴 紙おむつ

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994024557A1 (fr) * 1993-04-16 1994-10-27 The United States Of America, As Represented By Th Article et procede permettant de detecter la presence de germes pathogenes dans des matieres fecales
US5468236A (en) * 1993-06-09 1995-11-21 Kimberly-Clark Corporation Disposable absorbent product incorporating chemically reactive substance
WO1999002985A1 (fr) * 1997-07-11 1999-01-21 Rosengreen Lea T Dispositif portable permettant de detecter du liquide amniotique
WO2000000233A1 (fr) * 1998-06-29 2000-01-06 The Procter & Gamble Company Article jetable avec detecteur de dejections

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CHEMICAL ABSTRACTS, vol. 131, no. 2, 12 July 1999 (1999-07-12) Columbus, Ohio, US; abstract no. 23557, XP002146683 & BR 9 605 451 A 4 August 1998 (1998-08-04) *
DATABASE WPI Derwent Publications Ltd., London, GB; AN 1999-074156 XP002146685 & JP 10 313894 A (DAIKI KK), 2 December 1998 (1998-12-02) *

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8128912B2 (en) 2000-08-18 2012-03-06 Psimedica Limited Method of protecting skin from UV radiation using a dermatological composition having porous silicon
WO2002015863A1 (fr) * 2000-08-18 2002-02-28 Psimedica Limited Composition dermatologique
JP4534388B2 (ja) * 2001-06-13 2010-09-01 富士レビオ株式会社 経血又は膣分泌物採取器具、キット及び方法
JP2002372527A (ja) * 2001-06-13 2002-12-26 Fujirebio Inc 経血又は膣分泌物採取器具、キット及び方法
US7365238B2 (en) 2002-02-19 2008-04-29 The Procter And Gamble Company Absorbent article having a dehydration indicator
US7994079B2 (en) 2002-12-17 2011-08-09 Kimberly-Clark Worldwide, Inc. Meltblown scrubbing product
US8124363B2 (en) 2004-10-22 2012-02-28 Kimberly-Clark Worldwide, Inc. Detection of Trichomonas
US7514230B2 (en) 2004-10-22 2009-04-07 Kimberly-Clark Worldwide, Inc. Detection of trichomonas
WO2006046990A1 (fr) * 2004-10-22 2006-05-04 Kimberly-Clark Worldwide, Inc. Detection de la trichomonose
JP2010088429A (ja) * 2008-10-06 2010-04-22 Sony Deutsche Gmbh チオール分析物用センサ、センサアレイおよびチオール分析物の検出方法
EP2172769A1 (fr) 2008-10-06 2010-04-07 Sony Corporation Détecteur pour analyses de thiol
US8252606B2 (en) 2008-10-06 2012-08-28 Sony Corporation Sensor for thiol analytes
US9034593B2 (en) 2010-11-22 2015-05-19 Kimberly-Clark Worldwide, Inc. Vaginal indicator to detect biomarkers of good health
US20160066894A1 (en) * 2014-03-21 2016-03-10 Razzberry Inc. Health state monitoring device

Also Published As

Publication number Publication date
AU4803000A (en) 2000-11-10
CA2370936A1 (fr) 2000-11-02
CA2370502A1 (fr) 2000-11-02
JP2002542845A (ja) 2002-12-17
AU4802900A (en) 2000-11-10
AU4665900A (en) 2000-11-10
JP2002543397A (ja) 2002-12-17
WO2000065347A9 (fr) 2002-02-21
EP1173605A2 (fr) 2002-01-23
EP1173618A1 (fr) 2002-01-23
EP1173759A2 (fr) 2002-01-23
AU4492400A (en) 2000-11-10
EP1173606A2 (fr) 2002-01-23
WO2000065347A3 (fr) 2001-03-01
AU4665800A (en) 2000-11-10
MXPA01010950A (es) 2002-05-06
MXPA01010946A (es) 2002-05-06
EP1173758A2 (fr) 2002-01-23
JP2002542846A (ja) 2002-12-17
CN1348501A (zh) 2002-05-08
CA2370509A1 (fr) 2000-11-02
BR0010059A (pt) 2002-01-15
WO2000065348A2 (fr) 2000-11-02
CA2367588A1 (fr) 2000-11-02
CA2370739A1 (fr) 2000-11-02
WO2000065084A2 (fr) 2000-11-02
MXPA01010948A (es) 2002-05-06
JP2002542843A (ja) 2002-12-17
JP2003517584A (ja) 2003-05-27
MXPA01010949A (es) 2002-05-06
WO2000065083A2 (fr) 2000-11-02
BR0010058A (pt) 2002-01-15
CN1349562A (zh) 2002-05-15
WO2000065083A3 (fr) 2001-02-08
MXPA01010952A (es) 2002-05-06
WO2000065096A1 (fr) 2000-11-02
WO2000065348A3 (fr) 2001-04-05
WO2000065084A3 (fr) 2001-04-12

Similar Documents

Publication Publication Date Title
EP1173758A2 (fr) Dispositif pour diagnostics multiples de la sante de la femme
US6436055B1 (en) Device having diarrhea diagnostic panel
US6342037B1 (en) Device having fecal component sensor
US6479727B1 (en) Diagnostic panel
US6399853B1 (en) Disposable article having fecal component sensor
US7982088B2 (en) Disposable article having a biosensor
CA2664651A1 (fr) Article absorbant contenant un dispositif d'analyse de l'ecoulement lateral
WO2000000822A1 (fr) Dispositif dote d'un detecteur de composant fecal
EP2198299A2 (fr) Dispositif diagnostic pour identifier la rupture de la membrane pendant la grossesse
EP1092151B2 (fr) Dispositif dote d'un detecteur de composant fecal
TW476640B (en) Disposable article, article for detecting the presence of vaginal infections, and absorbent interlabial device
EP1091773B1 (fr) Article jetable avec detecteur de dejections
TW467736B (en) Feminine sanitary disposable article having a blood detection means as sensor
KR20020000877A (ko) 센서로서 혈액 검출 수단을 갖는 여성의 일회용 위생 제품

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ CZ DE DE DK DK DM EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AL AM AT AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ CZ DE DE DK DK DM EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

ENP Entry into the national phase

Ref document number: 2370739

Country of ref document: CA

Kind code of ref document: A

Ref document number: 2370739

ENP Entry into the national phase

Ref document number: 2000 614036

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: PA/a/2001/010946

Country of ref document: MX

Ref document number: 2000930160

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2000930160

Country of ref document: EP

AK Designated states

Kind code of ref document: C2

Designated state(s): AE AL AM AT AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ CZ DE DE DK DK DM EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: C2

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

COP Corrected version of pamphlet

Free format text: PAGES 1/8-8/8, DRAWINGS, REPLACED BY NEW PAGES 1/8-8/8

WWW Wipo information: withdrawn in national office

Ref document number: 2000930160

Country of ref document: EP